Avidity Biosciences, Inc. — Form D

Avidity Biosciences, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-19. The offering totals $400.2M, of which $400.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Carsten Michael BoessDirectorSan Diego, CA
Sarah BoyceDirectorSan Diego, CA
Noreen Michael HenigDirectorSan Diego, CA
Edward Michael KayeDirectorSan Diego, CA
Jean Michael KimDirectorSan Diego, CA
Tamar Michael ThompsonDirectorSan Diego, CA
Troy Michael WilsonDirectorSan Diego, CA
Sarah BoyceExecutive OfficerSan Diego, CA
W. Michael FlanaganExecutive OfficerSan Diego, CA
Arthur LevinExecutive OfficerSan Diego, CA
Michael Michael MacLeanExecutive OfficerSan Diego, CA
Teresa Michael McCarthyExecutive OfficerSan Diego, CA
Roderick WongDirectorNew York, NY
MICHAEL MARTINDirectorMinneapolis, MN
Troy WilsonDirectorSan Francisco, CA
Troy WilsonExecutive OfficerSan Francisco, CA
Todd BradyDirectorAtlanta, GA
EDWARD KAYEDirectorLA JOLLA, CA
NOREEN HENIGDirectorLA JOLLA, CA
P. Kent HawrylukExecutive OfficerCarmel, IN
Troy Wilson PhD., JDDirectorLa Jolla, CA
Troy Wilson PhD., JDExecutive OfficerLa Jolla, CA
Michael Martin PhD.DirectorLa Jolla, CA
Mark E DavisDirectorLa Jolla, CA
Frank E McCormickDirectorLa Jolla, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2019-11-13D$103.8M$100.5M
2017-01-06D$23.3M$18.0M
2014-02-18D$9.1M$9.1M
2014-02-18D/A$9.1M$9.1M

More